← Back to Search

Implicit Priming for Obesity

N/A

Recruiting

Led By Jason Tregellas, PhD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 18-65 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 12 weeks

Awards & highlights

Study Summary

This trial will test how different ways of thinking about food can affect eating habits and weight.

Who is the study for?

This trial is for adults aged 18-65 with obesity, defined as having a BMI of 27 or greater. It's not suitable for pregnant individuals or those who cannot undergo MRI scans due to metal or electronic devices in their body.Check my eligibility

What is being tested?

The study tests how 'Active Implicit Priming' and 'Control Implicit Priming' interventions influence brain reactions to food, eating habits, and weight when compared to a 'Food Exposure Task'.See study design

What are the potential side effects?

Since this trial involves behavioral interventions rather than medications, side effects may include discomfort from discussing eating habits or undergoing MRIs but are generally minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Food Image Ratings

Change in Food Intake

Percent Change in Blood Oxygen Level Dependent (BOLD) Response to Visual Food Cues as Measured by Functional Magnetic Resonance Imaging

Secondary outcome measures

Change in Fat Mass

Percent Change in Body Weight

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Active Implicit PrimingExperimental Treatment1 Intervention

Participants will complete active implicit priming, in which food images are implicitly primed (i.e., below conscious awareness) with images of positive or negative affect. This will be completed on a weekly basis for 12 weeks, for approximately 10 minutes each time.

Group II: Food Exposure TaskActive Control1 Intervention

Participants will complete a Food Exposure Task, in which they will be asked to smell, feel, lick, and imagine eating food items, but without actually eating them. This will be completed on a weekly basis for 12 weeks, for approximately 10-30 minutes each time.

Group III: Control Implicit PrimingPlacebo Group1 Intervention

Participants will complete control implicit priming, which matches the active intervention, but with neutral stimuli as primes. This will be completed on a weekly basis for 12 weeks, for approximately 10 minutes each time.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Active Implicit Priming

2013

N/A

~100

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,738 Previous Clinical Trials

2,149,298 Total Patients Enrolled

100 Trials studying Obesity

213,481 Patients Enrolled for Obesity

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,314,363 Total Patients Enrolled

446 Trials studying Obesity

588,710 Patients Enrolled for Obesity

Jason Tregellas, PhDPrincipal InvestigatorUniversity of Colorado, Denver

1 Previous Clinical Trials

76 Total Patients Enrolled

1 Trials studying Obesity

76 Patients Enrolled for Obesity

Media Library

Active Implicit Priming Clinical Trial Eligibility Overview. Trial Name: NCT05107908 — N/A

Obesity Research Study Groups: Active Implicit Priming, Control Implicit Priming, Food Exposure Task

Obesity Clinical Trial 2023: Active Implicit Priming Highlights & Side Effects. Trial Name: NCT05107908 — N/A

Active Implicit Priming 2023 Treatment Timeline for Medical Study. Trial Name: NCT05107908 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have joined the study thus far?

"Affirmative. Information on clinicaltrials.gov confirms that this medical experiment, first posted November 12th 2021, is actively searching for recruits. This trial requires a total of 228 patients from 1 site to complete the research."

Answered by AI

Might I be eligible to participate in this clinical research?

"The qualifications for this medical trial include a BMI of greater than 30 and participants must be aged between 18-65. Currently, 228 individuals are being recruited to take part in the study."

Answered by AI

Is the eligibility requirement for this medical trial confined to those under 80 years of age?

"Eligible participants must meet the age cut-off of 18 years and be below 65."

Answered by AI

Is this experiment open to enrolling participants?

"The trial is presently in search of participants. The initial advertisement was launched on November 12th 2021, and the latest update to their listing occurred five days later."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

2021. "Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05107908.